Pacific Biosciences of California Inc. (PACB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Pacific Biosciences of Ca...

    NASDAQ: PACB · Real-Time Price · USD
    1.49
    0.06 (4.20%)
    At close: Oct 03, 2025, 3:59 PM
    1.49
    0.00%
    After-hours: Oct 03, 2025, 07:32 PM EDT

    Pacific Biosciences of California Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 154.01M 200.52M 128.3M 130.51M
    Cost of Revenue
    		 116.73M 147.74M 79.27M 71.65M
    Gross Profit
    		 37.28M 52.78M 49.03M 58.86M
    Operating Income
    		 -474.31M -334.47M -307.2M -210.44M
    Interest Income
    		 n/a n/a n/a n/a
    Pretax Income
    		 -309.54M -318.16M -314.25M -274.87M
    Net Income
    		 -309.85M -306.74M -314.25M -181.22M
    Selling & General & Admin
    		 175.02M 169.82M 160.85M 124.12M
    Research & Development
    		 134.92M 187.17M 193M 112.9M
    Other Expenses
    		 201.66M 30.26M 2.38M 32.27M
    Operating Expenses
    		 511.6M 387.25M 356.23M 269.3M
    Interest Expense
    		 13.41M 14.34M 14.69M 12.53M
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 628.33M 534.99M 435.5M 340.95M
    Income Tax Expense
    		 316K -11.42M n/a -93.65M
    Shares Outstanding (Basic)
    		 274.49M 253.63M 224.55M 203.62M
    Shares Outstanding (Diluted)
    		 288.37M 253.63M 224.55M 204.14M
    EPS (Basic)
    		 -1.13 -1.21 -1.4 -0.89
    EPS (Diluted)
    		 -1.07 -1.21 -1.4 -0.89
    EBITDA
    		 -242.78M -271.13M -282.24M -250.76M
    EBIT
    		 -296.12M -303.82M -299.56M -262.34M
    Depreciation & Amortization
    		 53.35M 32.69M 17.32M 11.59M

    Add to Watchlist